Abstract
Pancreatic cancer is the seventh most prevalent cause of mortality globally. Since time immemorial, plant-derived products have been in use as therapeutic agents due to the existence of biologically active molecules called secondary metabolites. Flavonoids obtained from plants participate in cell cycle arrest, induce autophagy and apoptosis, and decrease oxidative stress in pancreatic cancer. The present study involves network pharmacology-based study of the methanolic leaf extract of Trema orientalis (MLETO) Linn. From the high-resolution mass spectrometry (HRMS) analysis, 21 nucleated flavonoids were screened out, of which only apigeniflavan was selected for further studies because it followed Lipinski’s rule and showed no toxicity. The pharmacokinetics and physiochemical characteristics of apigeniflavan were performed using the online web servers pkCSM, Swiss ADME, and ProTox-II. This is the first in silico study to report the efficiency of apigeniflavan in pancreatic cancer treatment. The targets of apigeniflavan were fetched from SwissTargetPrediction database. The targets of pancreatic cancer were retrieved from DisGeNET and GeneCards. The protein–protein interaction of the common genes using Cytoscape yielded the top five hub genes: KDR, VEGFA, AKT1, SRC, and ESR1. Upon molecular docking, the lowest binding energies corresponded to best docking score which indicated the highest protein–ligand affinity. Kyoto Encyclopaedia of Genes and Genomes (KEGG) database was employed to see the involvement of hub genes in pathways related to pancreatic cancer. The following, pancreatic cancer pathway, MAPK, VEGF, PI3K–Akt, and ErbB signaling pathways, were found to be significant. Our results indicate the involvement of the hub genes in tumor growth, invasion and proliferation in the above-mentioned pathways, and therefore necessitating their downregulation. Moreover, apigeniflavan can flourish as a promising drug for the treatment of pancreatic cancer in future.
Similar content being viewed by others
Data availability
Public databases have the data needed to validate the findings of this study.
Abbreviations
- HRMS:
-
High-resolution mass spectrometry
- MLETO:
-
Methanolic leaf extract of Trema orientalis
- KEGG:
-
Kyoto encyclopaedia of genes and genomes
- ROS:
-
Reactive oxygen species
- PPI:
-
Protein–protein interaction
- ADME:
-
Absorption, distribution, metabolism, and excretion
- HBD:
-
Hydrogen bond donor
- HBA:
-
Hydrogen bond acceptor
- TPSA:
-
Topological polar surface area
- DL:
-
Druglikeness
- MR:
-
Molar refractivity
- HIA:
-
Human intestinal absorption
- BBB:
-
Blood–brain barrier
- CNS:
-
Central nervous system
- OCT2:
-
Organic cation transporter 2 substrate
- CYP2D6:
-
CYP2D6 Cytochrome P450 2D6
- CYP3A4:
-
Cytochrome P450 3A4
- hERG:
-
Human ether-a-go-go related gene
- LOAEL:
-
Lowest-observed adverse-effect level
- LD50:
-
Lethal dose 50
- TCMSP:
-
Traditional Chinese medicine systems pharmacology database and analysis platform
- STRING:
-
Search tool for the retrieval of interacting genes/proteins
- GO:
-
Gene ontology
- DAVID:
-
Database for annotation, visualization and integrated discovery
- GEPIA:
-
Gene expression profiling interactive analysis
- MW:
-
Molecular weight
- ADMET:
-
Absorption, distribution, metabolism, excretion, and toxicity
References
Adinortey MB, Galyuon IK, Asamoah NO (2013) Trema orientalis Linn. Blume: A potential for prospecting for drugs for various uses. Pharmacogn Rev 7(13):67–72. https://doi.org/10.4103/0973-7847.112852
Ascenzi P, Bocedi A, Marino M (2006) Structure-function relationship of estrogen receptor alpha and beta: impact on human health. Mol Aspects Med 27(4):299–402. https://doi.org/10.1016/j.mam.2006.07.001
Baker CH, Trevino JG, Summy JM, Zhang F, Caron A, Nesbit M, Gallick GE, Fidler IJ (2006) Inhibition of PDGFR phosphorylation and Src and Akt activity by GN963 leads to therapy of human pancreatic cancer growing orthotopically in nude mice. Int J Oncol 29(1):125–138
Bi YH, Zhang LH, Chen SJ, Ling QZ (2018) Antitumor mechanisms of Curcumae Rhizoma based on network pharmacology. Evid Based Complement Alternat Med 2018:4509892. https://doi.org/10.1155/2018/4509892
Boldes T, Merenbakh-Lamin K, Journo S, Shachar E, Lipson D, Yeheskel A, Pasmanik-Chor M, Rubinek T, Wolf I (2020) R269C variant of ESR1: high prevalence and differential function in a subset of pancreatic cancers. BMC Cancer 20(1):531. https://doi.org/10.1186/s12885-020-07005-x
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424. https://doi.org/10.3322/caac.21492
Carpten JD, Faber AL, Horn C, Donoho GP, Briggs SL, Robbins CM, Hostetter G, Boguslawski S, Moses TY, Savage S, Uhlik M, Lin A, Du J, Qian YW, Zeckner DJ, Tucker-Kellogg G, Touchman J, Patel K, Mousses S, Bittner M, Schevitz R, Lai MH, Blanchard KL, Thomas JE (2007) A transforming mutation in the pleckstrin homology domain of AKT1 in cancer. Nature 448(7152):439–444. https://doi.org/10.1038/nature05933
Chandran U, Mehendale N, Tillu G, Patwardhan B (2015) Network Pharmacology of Ayurveda Formulation Triphala with Special Reference to Anti-Cancer Property. Comb Chem High Throughput Screen 18(9):846–854. https://doi.org/10.2174/1386207318666151019093606
Chang YT, Chang MC, Wei SC, Tien YW, Hsu C, Liang PC, Tsao PN, Jan IS, Wong JM (2008) Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer. Pancreas 37(2):145–150. https://doi.org/10.1097/MPA.0b013e318164548a
Costa G, González-Manzano S, González-Paramás A, Figueiredo IV, Santos-Buelga C, Batista MT (2015) Flavan hetero-dimers in the Cymbopogon citratus infusion tannin fraction and their contribution to the antioxidant activity. Food Funct 6(3):932–937. https://doi.org/10.1039/c5fo00042d
Costache MI, Ioana M, Iordache S, Ene D, Costache CA, Saftoiu A (2015) VEGF expression in pancreatic cancer and other malignancies: a review of the literature. Rom J Intern Med 53(3):199–208. https://doi.org/10.1515/rjim-2015-0027
Daina A, Michielin O, Zoete V (2019) SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res 47(W1):W357–W364. https://doi.org/10.1093/nar/gkz382
Doi Y, Yashiro M, Yamada N, Amano R, Ohira G, Komoto M, Hirakawa K (2010) Significance of phospho-vascular endothelial growth factor receptor-2 expression in pancreatic cancer. Cancer Sci 101(6):1529–1535. https://doi.org/10.1111/j.1349-7006.2010.01547.x
Ge SX, Jung D, Yao R (2020) ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics 36(8):2628–2629. https://doi.org/10.1093/bioinformatics/btz931
Golan T, Hammel P, Reni M, Van Cutsem E, Macarulla T, Hall MJ, Park JO, Hochhauser D, Arnold D, Oh DY, Reinacher-Schick A, Tortora G, Algül H, O’Reilly EM, McGuinness D, Cui KY, Schlienger K, Locker GY, Kindler HL (2019) Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer. N Engl J Med 381(4):317–327. https://doi.org/10.1056/NEJMoa1903387
Gresham GK, Wells GA, Gill S, Cameron C, Jonker DJ (2014) Chemotherapy regimens for advanced pancreatic cancer: a systematic review and network meta-analysis. BMC Cancer 14:471. https://doi.org/10.1186/1471-2407-14-471
Guo W, Chen Y, Gao J, Zhong K, Wei H, Li K, Tang M, Zhao X, Liu X, Nie C, Yuan Z (2019) Diosgenin exhibits tumor suppressive function via down-regulation of EZH2 in pancreatic cancer cells. Cell Cycle 18(15):1745–1758. https://doi.org/10.1080/15384101.2019.1632624
Gupta S, Kumar A, Tejavath KK (2021) A pharmacognostic approach for mitigating pancreatic cancer: emphasis on herbal extracts and phytoconstituents. Futur J Pharm Sci 7: 96. https://doi.org/10.1186/s43094-021-00246-y
Harris PA, Cheung M, Hunter RN 3rd, Brown ML, Veal JM, Nolte RT, Wang L, Liu W, Crosby RM, Johnson JH, Epperly AH, Kumar R, Luttrell DK, Stafford JA (2005) Discovery and evaluation of 2-anilino-5-aryloxazoles as a novel class of VEGFR2 kinase inhibitors. J Med Chem 48(5):1610–1619. https://doi.org/10.1021/jm049538w
Huang JJ, Yeo CJ, Sohn TA, Lillemoe KD, Sauter PK, Coleman J, Hruban RH, Cameron JL (2000) Quality of life and outcomes after pancreaticoduodenectomy. Ann Surg 231(6):890–898. https://doi.org/10.1097/00000658-200006000-00014
Javed I, Abbasi BA, Mahmood T, Kanwal S, Ali B, Shah SA, Khalil AT (2017) Plant-derived anticancer agents: a green anticancer approach. Asian Pac J Trop Biomed 7(12):1129–1150. https://doi.org/10.1016/j.apjtb.2017.10.016
Johnson JL, de Mejia EG (2013) Flavonoid apigenin modified gene expression associated with inflammation and cancer and induced apoptosis in human pancreatic cancer cells through inhibition of GSK-3β/NF-κB signaling cascade. Mol Nutr Food Res 57(12):2112–2127. https://doi.org/10.1002/mnfr.201300307
Kabir M, Al-Noman A, Dash BK, Hasan M, Akhter S, Rahman M (2019) Trema orientalis (Linn.) leaves promotes anticancer activity in Ehrlich ascites carcinoma (EAC) in Swiss albino mice. J Basic Clin Physiol Pharmacol. https://doi.org/10.1515/jbcpp-2019-0121
Kanehisa M, Furumichi M, Sato Y, Ishiguro-Watanabe M, Tanabe M (2021) KEGG: integrating viruses and cellular organisms. Nucleic Acids Res 49(D1):D545–D551. https://doi.org/10.1093/nar/gkaa970
Kim A, Ha J, Kim J, Cho Y, Ahn J, Cheon C, Kim SH, Ko SG, Kim B (2021) Natural products for pancreatic cancer treatment: from traditional medicine to modern drug discovery. Nutrients 13(11):3801. https://doi.org/10.3390/nu13113801
Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, Li Q, Shoemaker BA, Thiessen PA, Yu B, Zaslavsky L, Zhang J, Bolton EE (2023) PubChem 2023 update. Nucleic Acids Res 51(D1):D1373–D1380. https://doi.org/10.1093/nar/gkac956
Kopustinskiene DM, Jakstas V, Savickas A, Bernatoniene J (2020) Flavonoids as anticancer agents. Nutrients 12(2):457. https://doi.org/10.3390/nu12020457
Kumar P, Singh AK, Verma P, Tiwari KN, Mishra SK (2022) Network pharmacology-based study on apigenin present in the methanolic fraction of leaves extract of Cestrum nocturnum L. to uncover mechanism of action on hepatocellular carcinoma. Med Oncol 39(10):155. https://doi.org/10.1007/s12032-022-01759-z
Lee J, Kim JH (2016) Kaempferol inhibits pancreatic cancer cell growth and migration through the blockade of EGFR-related pathway in vitro. PloS One 11(5): e0155264. https://doi.org/10.1371/journal.pone.0155264
Lesslie DP, Gallick GE (2005) Src family kinases as regulators of angiogenesis: therapeutic implications. Curr Cancer Therapy Rev 1:45–50. https://doi.org/10.2174/1573394052952500
Lipinski CA (2004) Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol 1(4):337–341. https://doi.org/10.1016/j.ddtec.2004.11.007
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46(1–3):3–26. https://doi.org/10.1016/s0169-409x(00)00129-0
Long J, Liu Z, Hui L (2019) Anti-tumor effect and mechanistic study of elemene on pancreatic carcinoma. BMC Complement Altern Med 19(1):133. https://doi.org/10.1186/s12906-019-2544-2
Luo J, Manning BD, Cantley LC (2003) Targeting the PI3K–Akt pathway in human cancer: rationale and promise. Cancer Cell 4(4):257–262. https://doi.org/10.1016/s1535-6108(03)00248-4
Mizrahi JD, Surana R, Valle JW, Shroff RT (2020) Pancreatic cancer. Lancet 395(10242):2008–2020. https://doi.org/10.1016/S0140-6736(20)30974-0
Mohammed S, Mohammed Abdullah J, Shofiul A, Babar ZM (2017) In vivo antidiarrheal activity of methanolic extract of Trema orientalis leaves. Pharmacologyonline 187–192. ISSN: 1827–8620
Muller YA, Heiring C, Misselwitz R, Welfle K, Welfle H (2002) The cystine knot promotes folding and not thermodynamic stability in vascular endothelial growth factor. J Biol Chem 277(45):43410–43416. https://doi.org/10.1074/jbc.M206438200
National Center for Biotechnology Information (2022) PubChem Compound Summary for CID 44257189 Apigeniflavan. https://pubchem.ncbi.nlm.nih.gov/compound/Apigeniflavan. Accessed 27 August 2022
Nwachukwu JC, Srinivasan S, Bruno NE, Nowak J, Wright NJ, Minutolo F, Rangarajan ES, Izard T, Yao XQ, Grant BJ, Kojetin DJ, Elemento O, Katzenellenbogen JA, Nettles KW (2017) Systems structural biology analysis of ligand effects on erα predicts cellular response to environmental estrogens and anti-hormone therapies. Cell Chem Biol 24(1):35–45. https://doi.org/10.1016/j.chembiol.2016
Olanlokun JO, David OM, Afolayan AJ (2017) In vitro antiplasmodial activity and prophylactic potentials of extract and fractions of Trema orientalis (Linn.) stem bark. BMC Complement Altern Med 17(1):407. https://doi.org/10.1186/s12906-017-1914-xa
Pallauf K, Duckstein N, Rimbach G (2017) A literature review of flavonoids and lifespan in model organisms. Proc Nutr Soc 76(2):145–162. https://doi.org/10.1017/S0029665116000720
Parsons SJ, Parsons JT (2004) Src family kinases, key regulators of signal transduction. Oncogene 23(48):7906–7909. https://doi.org/10.1038/sj.onc.1208160
Pinero J, Sauch J, Sanz F, Furlong LI (2021) The DisGeNET cytoscape app: Exploring and visualizing disease genomics data. Comput Struct Biotechnol J 19:2960–2967. https://doi.org/10.1016/j.csbj.2021.05.015
Ponte LGS, Pavan ICB, Mancini MCS, da Silva LGS, Morelli AP, Severino MB, Bezerra RMN, Simabuco FM (2021) The hallmarks of flavonoids in cancer. Molecules 26(7):2029. https://doi.org/10.3390/molecules26072029
Qamar MT, Ashfaq UA, Tusleem K, Mumtaz A, Tariq Q, Goheer A, Ahmed B (2017) In-silico identification and evaluation of plant flavonoids as dengue NS2B/NS3 protease inhibitors using molecular docking and simulation approach. Pak J Pharm Sci 30(6):2119–2137
Rahman MM, Bairagi N, Kabir MM, Uddin MJ (2018) antibacterial potentiality and brine shrimp lethality bioassay of the methanol extract of Trema orientalis Leaves. South Asian Res J Natl Products 26:1–9. https://doi.org/10.9734/SARJNP/2018/41394
Rana R, Amran S, Chowdhury A (2018) Antitumor and cytotoxic effect of different partitionates of methanol extract of Trema orientalis: a preliminary in-vitro study. J Ayur Int Med Sci 3(4):44–50. https://doi.org/10.21760/JAIMS.V3I4.13283
Rangarajan P, Subramaniam D, Paul S, Kwatra D, Palaniyandi K, Islam S, Harihar S, Ramalingam S, Gutheil W, Putty S, Pradhan R, Padhye S, Welch DR, Anant S, Dhar A (2015) Crocetinic acid inhibits hedgehog signaling to inhibit pancreatic cancer stem cells. Oncotarget 6(29):27661–27673. https://doi.org/10.18632/oncotarget.4871
Rawla P, Sunkara T, Gaduputi V (2019) Epidemiology of pancreatic cancer: global trends, etiology and risk factors. World J Oncol 10(1):10–27. https://doi.org/10.14740/wjon1166
Rodríguez De Luna SL, Ramírez-Garza RE, Serna Saldívar SO (2020) Environmentally friendly methods for flavonoid extraction from plant material: impact of their operating conditions on yield and antioxidant properties. ScientificWorldJournal 28(2020):6792069. https://doi.org/10.1155/2020/6792069
Ru J, Li P, Wang J, Zhou W, Li B, Huang C, Li P, Guo Z, Tao W, Yang Y, Xu X, Li Y, Wang Y, Yang L (2014) TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform 6:13. https://doi.org/10.1186/1758-2946-6-13
Sargent KM, Clopton DT, Lu N, Pohlmeier WE, Cupp AS (2016) VEGFA splicing: divergent isoforms regulate spermatogonial stem cell maintenance. Cell Tissue Res 363(1):31–45. https://doi.org/10.1007/s00441-015-2297-2
Sherman BT, Hao M, Qiu J, Jiao X, Baseler MW, Lane HC, Imamichi T, Chang W (2022) DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res 50(W1):W216–W221. https://doi.org/10.1093/nar/gkac194
Shibuya M (2006) Vascular endothelial growth factor (VEGF)-Receptor2: its biological functions, major signaling pathway, and specific ligand VEGF-E. Endothelium 13(2):63–69. https://doi.org/10.1080/10623320600697955
Shivanika C, Kumar D, Ragunathan V, Tiwari P, Sumitha A (2020) Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of natural compounds against the SARS-CoV-2 main-protease. J Biomol Struct Dyn 40(2):585–611. https://doi.org/10.1080/07391102.2020.1815584
Sohal DPS, Kennedy EB, Cinar P, Conroy T, Copur MS, Crane CH, Garrido-Laguna I, Lau MW, Johnson T, Krishnamurthi S, Moravek C, O’Reilly EM, Philip PA, Pant S, Shah MA, Sahai V, Uronis HE, Zaidi N, Laheru D (2020) Metastatic Pancreatic Cancer: ASCO Guideline Update. J Clin Oncol https://doi.org/10.1200/JCO.20.01364
Starling N, Neoptolemos J, Cunningham D (2006) Role of erlotinib in the management of pancreatic cancer. Ther Clin Risk Manag 2(4):435–445. https://doi.org/10.2147/tcrm.2006.2.4.435
Stelzer G, Rosen N, Plaschkes I, Zimmerman S, Twik M, et al (2016) The GeneCards suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinformatics 54:1.30.1–33. https://doi.org/10.1002/cpbi.5
Trevino JG, Summy JM, Lesslie DP, Parikh NU, Hong DS, Lee FY, Donato NJ, Abbruzzese JL, Baker CH, Gallick GE (2006) Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model. Am J Pathol 168(3):962–972. https://doi.org/10.2353/ajpath.2006.050570
Uddin SN, Yesmin MN, Pramanik M, Akond, (2009) Anti-inflammatory, antinociceptive and diuretic activities of Trema orientalis Linn. Orient Pharm Exp Med 9(4):320–325. https://doi.org/10.3742/OPEM.2009.9.4.320
Vargas JAR, Lopez AG, Pinol MC, Froeyen M (2018) Molecular docking study on the interaction between 2-substituted-4,5-difuryl imidazoles with different protein target for antileishmanial activity. J Appl Pharm Sci 8(3):14–22. https://doi.org/10.7324/JAPS.2018.8303
Xu W, Harrison SC, Eck MJ (1997) Three-dimensional structure of the tyrosine kinase c-Src. Nature 385(6617):595–602. https://doi.org/10.1038/385595a0
Zhang L, Sanagapalli S, Stoita A (2018) Challenges in diagnosis of pancreatic cancer. World J Gastroenterol 24(19):2047–2060. https://doi.org/10.3748/wjg.v24.i19.2047
Zhou BP, Liao Y, Xia W, Spohn B, Lee MH, Hung MC (2001) Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat Cell Biol 3(3):245–252. https://doi.org/10.1038/35060032
Acknowledgements
The author, Richa Das, gratefully acknowledges the Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology, Banaras Hindu University, and Parul Institute of Applied Science, Parul University, for their immense support.
Funding
No specific grant was received for this work by funding organizations in the public, private, or not-for-profit sectors.
Author information
Authors and Affiliations
Contributions
SKM and KNT: developed the concept and design of the work. RD, SA, PK, and AKS: data collection, analysis, and interpretation of results. IB, AKT, and KNT: revision of manuscript. PKS: fractionation.
Corresponding author
Ethics declarations
Conflict of interest
The author declares no conflict of interest.
Ethical approval
This study did not involve the use of any human or animal model.
Informed consent
Not applicable.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Das, R., Agrawal, S., Kumar, P. et al. Network pharmacology of apigeniflavan: a novel bioactive compound of Trema orientalis Linn. in the treatment of pancreatic cancer through bioinformatics approaches. 3 Biotech 13, 160 (2023). https://doi.org/10.1007/s13205-023-03570-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s13205-023-03570-7